Stephen P. Squinto, EVP, Chief Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 14,125 shares at $116.12 ($1.6M) on 2013-08-02, disclosed to the SEC on 2013-08-02.
Scheduled sale ($1.6M) by EVP, Chief Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.95 | 4,858 | $558K | 34.3% |
| 2 | $115.05 | 4,912 | $565K | 34.7% |
| 3 | $116.04 | 2,963 | $344K | 21.1% |
| 4 | $116.12 | 1,392 | $162K | 9.9% |
| Total | $115.33 avg | 14,125 | $1.6M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |